RTW INVESTMENTS, LP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2021$10,467,000
-58.5%
3,806,018
-9.5%
0.15%
-59.8%
Q3 2021$25,241,000
+23.2%
4,206,7650.0%0.38%
+23.3%
Q2 2021$20,487,000
+97.2%
4,206,7650.0%0.31%
+90.7%
Q1 2021$10,391,000
-4.2%
4,206,765
+6.3%
0.16%
-11.0%
Q4 2020$10,845,000
+78.4%
3,958,130
+0.3%
0.18%
+24.7%
Q3 2020$6,079,000
-17.5%
3,947,518
+0.8%
0.15%
-29.5%
Q2 2020$7,365,000
+11.6%
3,917,622
+0.9%
0.21%
-27.1%
Q1 2020$6,602,000
-39.3%
3,883,490
+3.6%
0.28%
-30.7%
Q4 2019$10,875,000
+360.6%
3,750,107
+0.1%
0.41%
+192.9%
Q3 2019$2,361,0003,747,6990.14%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders